Envoy Medical shares surge 20.03% intraday as sector leaders rotate capital into equity warrant and stock builds base near support.

Envoy Medical Inc. surged 20.03% intraday after sector leaders rotated capital into the equity warrant, signaling institutional interest and potential liquidity inflows. The move aligns with the firm's technical setup as traders observed a potential base-building phase near a support level, though the immediate catalyst appears driven by smart money capital reallocation rather than fundamental developments.